GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a substantial innovation in how we handle high blood sugar. These new drugs work by stimulating the body’s own GLP-1 process, which supports https://altbookmark.com/story23662220/glp-1-a-revolutionary-advance-in-diabetes-care